![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, November 15, 2006 1:58:47 AM
Ellipsis Biotherapeutics is a wholly owned subsidiary of DNAPrint™ genomics . DNAPrint specializes in Forensic Science, Genealogical Research, and Pharmaceutical development. Ellipsis Biotherapeutics, formerly privately held, has retained its name and functions as a Canadian company from its corporate headquarters in Toronto, Ontario. Ellipsis has retained its existing personnel and continues to be managed by Dr. Laurence Rubin
Trace Genetics (www.tracegenetics.com)
Trace Genetics, based in Richmond, California, is another wholly owned subsidiary of DNAPrint™ genomics. Trace Genetics is a full service DNA laboratory, with expertise in Gene Genealogy, Forensics, Molecular Diagnostics and Population Genetics.
Ann
FEATURED Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • Sep 9, 2024 9:34 AM
North Bay Resources Commences Gold Shipments, Fran Gold Project, British Columbia; Enters Taber Gold Mine JV, Sierra County, California • NBRI • Sep 9, 2024 9:15 AM
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM